86 related articles for article (PubMed ID: 19516086)
1. Effect of monosodium olpadronate on osteoclasts and megakaryocytes: an in vivo study.
Escudero ND; Lacave M; Ubios AM; Mandalunis PM
J Musculoskelet Neuronal Interact; 2009; 9(2):109-20. PubMed ID: 19516086
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of vascular endothelial growth factor (VEGF) in interradicular bone marrow in olpadronate treated animals.
Bigi MM; Escudero ND; Ubios AM; Mandalunis PM
Acta Odontol Latinoam; 2010; 23(3):265-9. PubMed ID: 21638970
[TBL] [Abstract][Full Text] [Related]
3. Reduced RANKL expression impedes osteoclast activation and tooth eruption in alendronate-treated rats.
Bradaschia-Correa V; Moreira MM; Arana-Chavez VE
Cell Tissue Res; 2013 Jul; 353(1):79-86. PubMed ID: 23636419
[TBL] [Abstract][Full Text] [Related]
4. Differentiation and functions of osteoclasts and odontoclasts in mineralized tissue resorption.
Sasaki T
Microsc Res Tech; 2003 Aug; 61(6):483-95. PubMed ID: 12879416
[TBL] [Abstract][Full Text] [Related]
5. Minodronic acid influences receptor activator of nuclear factor kappaB ligand expression and suppresses bone resorption by osteoclasts in rats with collagen-induced arthritis.
Tanishima S; Kishimoto Y; Fukata S; Mizumura H; Hagino H; Teshima R
Mod Rheumatol; 2007; 17(3):198-205. PubMed ID: 17564774
[TBL] [Abstract][Full Text] [Related]
6. Cellular mechanism of inhibition of osteoclastic resorption of bone and calcified cartilage by long-term pamidronate administration in ovariectomized mature rats.
Mayahara M; Sasaki T
Anat Rec A Discov Mol Cell Evol Biol; 2003 Sep; 274(1):817-26. PubMed ID: 12923892
[TBL] [Abstract][Full Text] [Related]
7. Increased apoptosis in osteoclasts and decreased RANKL immunoexpression in periodontium of cimetidine-treated rats.
Longhini R; de Oliveira PA; de Souza Faloni AP; Sasso-Cerri E; Cerri PS
J Anat; 2013 Feb; 222(2):239-47. PubMed ID: 23198931
[TBL] [Abstract][Full Text] [Related]
8. Combination of beta-cryptoxanthin and zinc has potent effects on apoptotic cell death and suppression of bone resorption-related gene expression in osteoclastic cells.
Yamaguchi M; Uchiyama S
Int J Mol Med; 2008 Aug; 22(2):221-8. PubMed ID: 18636177
[TBL] [Abstract][Full Text] [Related]
9. Force-induced osteoclast apoptosis in vivo is accompanied by elevation in transforming growth factor beta and osteoprotegerin expression.
Kobayashi Y; Hashimoto F; Miyamoto H; Kanaoka K; Miyazaki-Kawashita Y; Nakashima T; Shibata M; Kobayashi K; Kato Y; Sakai H
J Bone Miner Res; 2000 Oct; 15(10):1924-34. PubMed ID: 11028444
[TBL] [Abstract][Full Text] [Related]
10. No reduction in circulating preosteoclasts 18 months after treatment with zoledronate: analysis from a randomized placebo controlled trial.
Dalbeth N; Pool B; Stewart A; Horne A; House ME; Cornish J; Reid IR
Calcif Tissue Int; 2013 Jan; 92(1):1-5. PubMed ID: 23052228
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of RANKL-dependent cellular fusion in pre-osteoclasts by amiloride and a NHE10-specific monoclonal antibody.
Mine Y; Shuto T; Nikawa H; Kawai T; Ohara M; Kawahara K; Ohta K; Kukita T; Terada Y; Makihira S
Cell Biol Int; 2015 Jun; 39(6):696-709. PubMed ID: 25612314
[TBL] [Abstract][Full Text] [Related]
12. Decrease in the number and apoptosis of alveolar bone osteoclasts in estrogen-treated rats.
Faloni AP; Sasso-Cerri E; Katchburian E; Cerri PS
J Periodontal Res; 2007 Jun; 42(3):193-201. PubMed ID: 17451538
[TBL] [Abstract][Full Text] [Related]
13. Effect of topical administration of monosodium olpadronate on experimental periodontitis in rats.
Goya JA; Paez HA; Mandalunis PM
J Periodontol; 2006 Jan; 77(1):1-6. PubMed ID: 16579696
[TBL] [Abstract][Full Text] [Related]
14. Differences in osteoclast formation between proximal and distal tibial osteoporosis in rats with adjuvant arthritis: inhibitory effects of bisphosphonates on osteoclasts.
Shu G; Yamamoto K; Nagashima M
Mod Rheumatol; 2006; 16(6):343-9. PubMed ID: 17164994
[TBL] [Abstract][Full Text] [Related]
15. CCR1 chemokines promote the chemotactic recruitment, RANKL development, and motility of osteoclasts and are induced by inflammatory cytokines in osteoblasts.
Yu X; Huang Y; Collin-Osdoby P; Osdoby P
J Bone Miner Res; 2004 Dec; 19(12):2065-77. PubMed ID: 15537451
[TBL] [Abstract][Full Text] [Related]
16. In vitro and in vivo responses to high and low doses of nitrogen-containing bisphosphonates suggest engagement of different mechanisms for inhibition of osteoclastic bone resorption.
Fisher JE; Rosenberg E; Santora AC; Reszka AA
Calcif Tissue Int; 2013 Jun; 92(6):531-8. PubMed ID: 23435531
[TBL] [Abstract][Full Text] [Related]
17. Beta-cryptoxanthin stimulates apoptotic cell death and suppresses cell function in osteoclastic cells: change in their related gene expression.
Uchiyama S; Yamaguchi M
J Cell Biochem; 2006 Aug; 98(5):1185-95. PubMed ID: 16514646
[TBL] [Abstract][Full Text] [Related]
18. Cocultures of osteoblasts and osteoclasts are influenced by local application of zoledronic acid incorporated in a poly(D,L-lactide) implant coating.
Greiner S; Kadow-Romacker A; Schmidmaier G; Wildemann B
J Biomed Mater Res A; 2009 Oct; 91(1):288-95. PubMed ID: 18980195
[TBL] [Abstract][Full Text] [Related]
19. Receptor activator of nuclear factor kappaB ligand (RANKL) is a key molecule of osteoclast formation for bone metastasis in a newly developed model of human neuroblastoma.
Michigami T; Ihara-Watanabe M; Yamazaki M; Ozono K
Cancer Res; 2001 Feb; 61(4):1637-44. PubMed ID: 11245477
[TBL] [Abstract][Full Text] [Related]
20. The mouse mammary tumor cell line, MMT060562, produces prostaglandin E2 and leukemia inhibitory factor and supports osteoclast formation in vitro via a stromal cell-dependent pathway.
Akatsu T; Ono K; Katayama Y; Tamura T; Nishikawa M; Kugai N; Yamamoto M; Nagata N
J Bone Miner Res; 1998 Mar; 13(3):400-8. PubMed ID: 9525340
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
